Press release
Dry Age-Related Macular Degeneration Pipeline Outlook, FDA Approvals, Emerging Drugs, and Companies 2024 (Updated)
Dry Age-Related Macular Degeneration Pipeline
Key Takeaways from the Dry Age-Related Macular Degeneration Pipeline Report
• DelveInsight's Dry Age-Related Macular Degeneration pipeline report depicts a robust space with 70+ active players working to develop 80+ pipeline therapies for Dry Age-Related Macular Degeneration treatment.
• The leading companies working in the Dry Age-Related Macular Degeneration market include Molecular Partners, Stealth BioTherapeutics, Regenerative Patch Technologies, Aevitas Therapeutics, NGM Biopharmaceuticals, InflammX Therapeutics, Lineage Cell Therapeutics, Alexion AstraZeneca Rare Disease, Belite Bio, Katairo, Cognition Therapeutics, Apellis Pharmaceuticals, Galimedix Therapeutics, Amarna Therapeutics, 4D Molecular Therapeutics, Aviceda Therapeutics, Isarna Therapeutics, and others.
• Promising Dry Age-Related Macular Degeneration Pipeline Therapies in the various stages of development include RPESC-RPE-4W, PRIMA, QA102, Active Comparator CT1812, ASP7317, Tacrolimus, OCU410, GT005, AVD-104, and others.
May 2024:- Novartis Pharmaceuticals- A 64-week, Two-arm, Randomized, Double-masked, Multicenter, Phase IIIb Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen in Patients With Neovascular Agerelated Macular Degeneration (TALON).
Request a sample and discover the recent advances in Dry Age-Related Macular Degeneration Treatment Drugs @ Dry Age-Related Macular Degeneration Pipeline Outlook Report- https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
The Dry Age-Related Macular Degeneration pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage Dry Age-Related Macular Degeneration drugs, inactive and dormant assets, a comprehensive assessment of driving and restraining factors, and an assessment of opportunities and risks in the Dry Age-Related Macular Degeneration clinical trial landscape.
Dry Age-Related Macular Degeneration Overview
Age-related macular degeneration (AMD) is a degenerative disease of the center area of the ocular-posterior segment (the macula lutea) that causes slow degeneration in central vision and severe disability in affected persons.
Find out more about Dry Age-Related Macular Degeneration Treatment Landscape @ Drugs for Dry Age-Related Macular Degeneration Treatment- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Dry Age-Related Macular Degeneration Emerging Drugs Profile
• ALK-001: Alkeus Pharmaceuticals
• Elamipretide: Stealth BioTherapeutics
• CPCB-RPE1: Regenerative Patch Technologies
• AAV.sFH: Aevitas Therapeutics
Dry Age-Related Macular Degeneration Pipeline Therapeutics Assessment
There are approx. 70+ key companies which are developing the therapies for Dry Age-related Macular Degeneration. The Dry Age-Related Macular Degeneration companies which have their Dry Age-related Macular Degeneration drug candidates in the most advanced stage, i.e. Phase III include, Alkeus Pharmaceuticals.
Learn more about the emerging Dry Age-Related Macular Degeneration Pipeline Therapies @ Dry Age-Related Macular Degeneration Clinical Trials Assessment- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Dry Age-Related Macular Degeneration Pipeline Report
• Coverage- Global
• Dry Age-Related Macular Degeneration Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Dry Age-Related Macular Degeneration Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Dry Age-Related Macular Degeneration Companies- Molecular Partners, Stealth BioTherapeutics, Regenerative Patch Technologies, Aevitas Therapeutics, NGM Biopharmaceuticals, InflammX Therapeutics, Lineage Cell Therapeutics, Alexion AstraZeneca Rare Disease, Belite Bio, Katairo, Cognition Therapeutics, Apellis Pharmaceuticals, Galimedix Therapeutics, Amarna Therapeutics, 4D Molecular Therapeutics, Aviceda Therapeutics, Isarna Therapeutics, and others.
• Dry Age-Related Macular Degeneration Pipeline Therapies- RPESC-RPE-4W, PRIMA, QA102, Active Comparator CT1812, ASP7317, Tacrolimus, OCU410, GT005, AVD-104, and others.
Dive deep into rich insights for new drugs for Dry Age-Related Macular Degeneration Treatment, Visit @ Dry Age-Related Macular Degeneration Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Dry Age-related Macular Degeneration: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Dry Age-related Macular Degeneration- DelveInsight's Analytical Perspective
7. Late Stage Products (Preregistration)
8. Abicipar pegol: Molecular Partners
9. Late Stage Products (Phase III)
10. ALK-001: Alkeus Pharmaceuticals
11. Drug profiles in the detailed report…..
12. Mid Stage Products (Phase II)
13. Elamipretide: Stealth BioTherapeutics
14. Drug profiles in the detailed report…..
15. Early Stage Products (Phase I)
16. Drug Name: Company Name
17. Drug profiles in the detailed report…..
18. Preclinical and Discovery Stage Products
19. AAV.sFH: Aevitas Therapeutics
20. Drug profiles in the detailed report…..
21. Inactive Products
22. Dry Age-related Macular Degeneration Key Companies
23. Dry Age-related Macular Degeneration Key Products
24. Dry Age-related Macular Degeneration- Unmet Needs
25. Dry Age-related Macular Degeneration- Market Drivers and Barriers
26. Dry Age-related Macular Degeneration- Future Perspectives and Conclusion
27. Dry Age-related Macular Degeneration Analyst Views
28. Dry Age-related Macular Degeneration Key Companies
29. Appendix
For further information on the Dry Age-Related Macular Degeneration Pipeline therapeutics, reach out to Dry Age-Related Macular Degeneration Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Other Important Links-
Stem Cell Market- https://www.delveinsight.com/report-store/stem-cell-market
Vulvar Cancer Market- https://www.delveinsight.com/report-store/vulvar-cancer-market
Vascular Grafts Market- https://www.delveinsight.com/report-store/vascular-grafts-market
Acne Vulgaris Market- https://www.delveinsight.com/report-store/acne-vulgaris-av-market
Bone Growth Stimulator Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Angiofibroma Market- https://www.delveinsight.com/report-store/angiofibroma-market
Atopic Dermatitis Market- https://www.delveinsight.com/report-store/atopic-dermatitis-market
Sepsis Market- https://www.delveinsight.com/report-store/sepsis-market
Tendonitis Market- https://www.delveinsight.com/report-store/tendonitis-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Ascites Market- https://www.delveinsight.com/report-store/ascites-market
Systemic Lupus Erythematosus Market- https://www.delveinsight.com/report-store/systemic-lupus-erythematosus-market
Post Operative Pain Management Market- https://www.delveinsight.com/report-store/post-operative-pain-management-market
Cxcr Inhibitors Market- https://www.delveinsight.com/report-store/c-x-c-chemokine-receptor-inhibitors-competitive-landscape-market-and-pipeline-analysis
Androgen Receptor Inhibitor Market- https://www.delveinsight.com/report-store/androgen-receptor-inhibitor-market-forecast
Antibody Drug Conjugate Market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
STS Devices Market- https://www.delveinsight.com/report-store/sts-devices-market
Positive Airway Pressure Device Market- https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Age-Related Macular Degeneration Pipeline Outlook, FDA Approvals, Emerging Drugs, and Companies 2024 (Updated) here
News-ID: 3510311 • Views: …
More Releases from DelveInsight
Renal Cancer Clinical Trials Analysis 2025: Next-Generation Targeted Therapies a …
DelveInsight's "Renal Cancer - Clinical Trials Analysis, 2025" explores the rapidly evolving therapeutic landscape for renal cell carcinoma (RCC), the most common form of kidney cancer. Despite advances with VEGF inhibitors, mTOR inhibitors, and immune checkpoint inhibitors, many patients with advanced or refractory RCC continue to experience limited long-term responses, highlighting the need for novel treatment strategies.
The renal cancer clinical trial pipeline is expanding with next-generation targeted agents, including HIF-2α…
Polymyositis Clinical Trial Analysis 2025: How Emerging Therapies Are Shaping th …
DelveInsight's "Polymyositis - Pipeline Insight, 2025" examines the evolving therapeutic landscape for polymyositis, a rare autoimmune inflammatory myopathy characterized by progressive muscle weakness and systemic complications. Despite current treatments relying largely on corticosteroids and immunosuppressants, many patients experience incomplete responses or long-term side effects, highlighting the urgent need for innovative therapies.
The polymyositis pipeline is expanding with targeted immunomodulatory agents, including JAK inhibitors, monoclonal antibodies against cytokines (such as IL-6 and…
Ulcerative Colitis Clinical Trials Analysis 2025: Advancing Biologics, Small Mol …
DelveInsight's "Ulcerative Colitis - Clinical Trials Analysis, 2025" reviews the expanding landscape of therapies in development for ulcerative colitis (UC), a chronic inflammatory bowel disease that continues to impose substantial morbidity worldwide. While anti-TNF biologics, JAK inhibitors, and S1P modulators have reshaped treatment in recent years, many patients with moderate-to-severe UC remain refractory, underscoring persistent unmet needs.
The UC clinical trial space is rapidly evolving, with next-generation IL-23 and TYK2 inhibitors,…
Amyloid Light-Chain Amyloidosis Clinical Trials Analysis 2025: Emerging Therapie …
DelveInsight's "Amyloid Light-Chain (AL) Amyloidosis - Clinical Trials Analysis, 2025" examines the evolving therapeutic landscape for Amyloid Light-Chain Amyloidosis, a rare and life-threatening disorder characterized by abnormal deposition of immunoglobulin light chains in vital organs. Despite advances with proteasome inhibitors, monoclonal antibodies, and autologous stem cell transplantation, many patients with advanced or refractory disease continue to face significant unmet medical needs.
The Amyloid Light-Chain Amyloidosis clinical trial landscape is rapidly expanding…
More Releases for Dry
Rising Prevalence Of Dry Eye Conditions Boosts Growth In Dry Eye Products Market …
The Dry Eye Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Dry Eye Products Market Size During the Forecast Period?
In recent years, there has been a significant expansion in the market size of dry eye products. The market is projected…
Dry Powder Inhalers Market - Breathe Freely: Dry Powder Inhalers Empowering Asth …
Newark, New Castle, USA: The "Dry Powder Inhalers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Dry Powder Inhalers Market: https://www.growthplusreports.com/report/dry-powder-inhalers-market/8762
This latest report researches the industry structure,…
Dry Eye Market - Advancing Eye Wellness: Dry Eye Solutions Revolutionizing Relie …
Newark, New Castle, USA - new report, titled Dry Eye Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Dry Eye market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Dry Eye market. The report offers an overview of the market, which…
Dry Lubricants Market Size to Hit $ 813.78 Million by 2028 | Dry Lubricants Indu …
According to our experience research team, Dry Lubricants Market was valued at USD 755.42 Million in 2021, and the global Dry Lubricants industry is projected to reach a value of USD 813.78 Million by 2028, at a CAGR of 1.2% during the forecast period 2022-2028
The report is focused on gaining various Dry Lubricants market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Dry Ice Market In-Depth Analysis | Key Participants Dry Ice Corp., Dry Ice UK Lt …
Demand for dry ice is expected to magnify with the development of dry ice machines industry across the globe. Manufacturers in large multinational organizations and private firms have been contributing prominently in the revenue growth of dry ice market. Dry ice being a cost-effective product is expected to bolster its demand across various applications in the near future. Rising number of fire accidents leads to increasing demand for dry ice,…
Dry Screw Vacuum Pumps
Swam Dry vacuum pumps are the latest development in the vacuum pump industry. They offer a number of advantages over traditional vacuum pump designs. Best process gas blowers. There is “NO OIL / NO WATER” contact with the process vapours, which is why they are considered extremely environmentally friendly.
Visit us for more info - http://swamatics.com/ProductDetails.aspx?prod=Process%20Gas%20Blowers/Gas%20Boosters
The definition of a dry vacuum pump is a pump that does not use any…
